STOK Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Stoke Therapeutics Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 12.41 USD 6.16%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast STOK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STOK is 24.14 USD with a low forecast of 17.17 USD and a high forecast of 36.75 USD.

STOK Lowest Forecast

Wall Street Target

STOK Average Forecast

Wall Street Target

STOK Highest Forecast

Wall Street Target

38% Upside

95% Upside

196% Upside

The latest public price target was made on Mar 26, 2024 by Joseph Stringer from Needham , who expects STOK stock to rise by 77% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Joseph Stringer Needham	22 USD Upside 77%	1 month ago Mar 26, 2024	Stoke Therapeutics (STOK) PT Raised to $22 at Needham, latest STK-001 'data put STOK in a strong position heading into regulatory discussions' StreetInsider
Sumant Kulkami Canaccord Genuity	21 USD Upside 69%	1 month ago Mar 26, 2024	Stoke Therapeutics (STOK) PT Raised to $21 at Canaccord Genuity StreetInsider

Price Target	22 USD
Upside/Downside	77%

Price Target	21 USD
Upside/Downside	69%

2Seventy Bio Inc

164% Upside

Veracyte Inc

63% Upside

Heron Therapeutics Inc

191% Upside

Japan Tissue Engineering Co Ltd

85% Upside

2Seventy Bio Inc

164% Upside

Veracyte Inc

63% Upside

Heron Therapeutics Inc

191% Upside

Japan Tissue Engineering Co Ltd

85% Upside

Krystal Biotech Inc

23% Upside

Kuros Biosciences AG

192% Upside

Pharming Group NV

106% Upside

Ovid Therapeutics Inc

141% Upside

Revenue
Forecast

The compound annual growth rate of Stoke Therapeutics Inc's revenue for the next 3 years is 57%.

N/A

57%

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-2%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-20%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for STOK is 24.14 USD with a low forecast of 17.17 USD and a high forecast of 36.75 USD.

The compound annual growth rate of Stoke Therapeutics Inc's revenue for the next 3 years is 57%.

Join more than 132,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.